People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Paradromics, Inc. | — | Other Health Care | Series C | $96.9M | $570.0M | 2018 |
Thomas R Krummel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas R Krummel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dakin Sloss | 1 | 9 |
| Amy Kruse | 1 | 4 |
| Ron Kelly | 1 | 3 |
| Thomas Krummel | 1 | 3 |
| Adam Kablanian | 1 | 3 |
| Zia Huque | 1 | 3 |
| James Burrows | 1 | 2 |
| Helmy Eltoukhy | 1 | 2 |
| Yifan Kong | 1 | 1 |
| Matthew Angle | 1 | 1 |
| Enkelejda Bashllari | 1 | 1 |
| Court Westcott | 1 | 1 |
| Matthew R Angle | 1 | 1 |
| Ron R Kelly | 1 | 1 |
| Enke R Bashllari | 1 | 1 |
| Edmund Huber | 1 | 1 |
| Matt Angle | 1 | 1 |
| Adam R Kablanian | 1 | 1 |
| Enke Bashllari | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.